Associations of Total and High-Molecular-Weight Adiponectin With All-Cause and Cardiovascular Mortality in Older Persons: The Cardiovascular Health Study
暂无分享,去创建一个
C. Mantzoros | D. Siscovick | S. Zieman | A. Arnold | L. Djoussé | J. Ix | R. Tracy | J. Kizer | K. Mukamal | D. Benkeser | C. Defilippi | A. Newman | Susan J. Zieman
[1] D. Siscovick,et al. Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People , 2012, Diabetes Care.
[2] P. Wilson,et al. Association of Adiponectin With Left Ventricular Mass in Blacks: The Jackson Heart Study , 2011, Circulation. Heart failure.
[3] J. Manson,et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. , 2011, Atherosclerosis.
[4] S. Kritchevsky,et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[5] P. Whincup,et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[6] K. Walsh,et al. Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.
[7] Joshua R. Cook,et al. Hypoadiponectinemia--cause or consequence of human "insulin resistance"? , 2010, The Journal of clinical endocrinology and metabolism.
[8] C. Vrints,et al. Functional Adiponectin Resistance at the Level of the Skeletal Muscle in Mild to Moderate Chronic Heart Failure , 2010, Circulation. Heart failure.
[9] J. Gottdiener,et al. Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. , 2010, Journal of the American College of Cardiology.
[10] S. Cummings,et al. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study , 2009, Diabetologia.
[11] N. Sattar,et al. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. , 2008, The Journal of clinical endocrinology and metabolism.
[12] L. Kuller,et al. Adiponectin and risk of coronary heart disease in older men and women. , 2008, The Journal of clinical endocrinology and metabolism.
[13] K. Walsh,et al. A novel role for adiponectin in the regulation of inflammation. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[14] D. Mozaffarian,et al. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. , 2008, Archives of internal medicine.
[15] D. Lawlor,et al. High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. , 2008, The Journal of clinical endocrinology and metabolism.
[16] T. Funahashi,et al. Prognostic value of adiponectin for cardiovascular disease and mortality. , 2008, The Journal of clinical endocrinology and metabolism.
[17] P. Whincup,et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. , 2007, Archives of internal medicine.
[18] W. Rathmann,et al. Adiponectin and Cardiovascular Mortality: Evidence for “Reverse Epidemiology” , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[19] E. Barrett-Connor,et al. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.
[20] Vineet Chopra,et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.
[21] S. Verma,et al. Adiponectin and myocardial infarction: A paradox or a paradigm? , 2006, European heart journal.
[22] Jan Frystyk,et al. Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.
[23] Cynthia J. Girman,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[24] John A Wagner,et al. Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.
[25] S. Kihara,et al. Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004, Circulation research.
[26] R. D'Agostino,et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. , 2003, The American journal of medicine.
[27] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[28] Paul H. C. Eilers,et al. Flexible smoothing with B-splines and penalties , 1996 .
[29] L H Kuller,et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.
[30] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[31] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[32] J. Robins,et al. Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.
[33] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[34] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[35] C. Mantzoros,et al. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. , 2013, The Journal of clinical endocrinology and metabolism.
[36] D. Mozaffarian,et al. Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. , 2011, American journal of epidemiology.
[37] R. Kronmal,et al. Multiple imputation of baseline data in the cardiovascular health study. , 2003, American journal of epidemiology.
[38] R. Tracy,et al. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.